Memorial Sloan Kettering Cancer Center
Clinical trials sponsored by Memorial Sloan Kettering Cancer Center, explained in plain language.
-
New combo therapy targets deadly brain cancer in early trial
Disease control Recruiting nowThis early-stage study tests whether two experimental drugs, ABBV-637 and ABBV-155, are safe when given alone or with another drug called ERAS-801 for people whose glioblastoma has come back. About 60 adults with a specific type of brain tumor (EGFR gene amplified) will take part…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 26, 2026 19:38 UTC
-
Hormone therapy before surgery may reduce cancer left behind in breast cancer patients
Disease control Recruiting nowThis study looks at whether giving hormone therapy before surgery helps women with a certain type of breast cancer (invasive lobular carcinoma) have cleaner surgical results. The goal is to see if this approach lowers the chance of cancer cells being found at the edges of removed…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 26, 2026 19:37 UTC
-
New hope for lung cancer patients with brain tumors: drug combo trial launches
Disease control Recruiting nowThis study tests a new drug called ivonescimab combined with standard chemotherapy and precise radiation (SRS) for people with non-small cell lung cancer that has spread to the brain. The goal is to find a safe dose and see if it helps control the brain tumors. About 53 adults wi…
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 24, 2026 16:17 UTC
-
Blood test may spare some throat cancer patients from unnecessary radiation
Disease control Recruiting nowThis study is for people with HPV-related throat cancer who have had or will have surgery. Researchers will use a blood test that looks for cancer DNA (HPV ctDNA) to decide if radiation therapy is needed. In one group, patients with no detectable cancer DNA after surgery will ski…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 24, 2026 16:17 UTC
-
New approach aims to tame inflammation before Life-Saving transplant
Disease control Recruiting nowThis study is testing two different drug treatments to see if they can reduce harmful inflammation in people with severe immune system disorders, making them better prepared to receive a stem cell transplant. Researchers want to know if these treatments help the donated stem cell…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 20, 2026 16:15 UTC
-
New support program aims to boost quality of life for chinese cancer patients
Symptom relief Recruiting nowThis study tests a support program for Chinese cancer patients and survivors. It combines education sessions, counseling, and peer support groups to see which mix works best. The goal is to improve quality of life. About 64 people from New York and New Jersey who speak Mandarin w…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Apr 23, 2026 12:44 UTC